ResearchMoz

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 Report Available at Researchmoz.us

ResearchMoz.us include new market research report" Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth Description" to its huge collection of research reports.

 

Albany, NY -- (ReleaseWire) -- 02/06/2014 -- GBI Research has released its pharma report “Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth”. The systemic psoriasis market is forecast to grow substantially over the forecast period from $5.0 billion in 2013 to $10.4 billion in 2020, across the eight major markets. This growth will be driven by a rising treatment population and the continued uptake of biologics.

Full Report With TOC @ http://www.researchmoz.us/systemic-psoriasis-therapeutics-in-major-developed-markets-to-2020-continued-uptake-of-biologics-and-novel-pipeline-drugs-to-drive-growth-description-report.html

Biologics will continue to drive market growth despite leading brands Enbrel (etanercept), Humira (adalimumab) and Remicade (infliximab) losing patent protection in most of the major markets over the forecast period. Although the market will suffer revenue losses as a result of sales erosion from biosimilar competitors, this will be offset by the emergence of novel therapies. Most notably, these include monoclonal antibodies secukinumab, ixekizumab and brodalumab, which are currently being developed by Alcon (Novartis subsidiary), Eli Lilly and Amgen, respectively.

Scope

An introduction to psoriasis, which includes symptoms, epidemiology, etiology, pathophysiology, diagnosis and treatment
Analysis of the major systemic therapies in the current psoriasis marketed landscape
Analysis of the pipeline for psoriasis, which includes a breakdown of pipeline molecules by phase of development, molecule type, molecular target and novelty. Psoriasis clinical trials are analyzed by size, duration and failure rates, and a comparative analysis of the most promising systemic pipeline molecules is also provided.
Forecast projections for the systemic psoriasis market to 2020. Analysis is provided for the global market and each of the eight major markets. The forecast incorporates projected, low and high variance scenarios based on treatment usage patterns and annual therapy costs in each of the major markets.
Analysis of strategic consolidations, including co-development and licensing deals, within the psoriasis indication

All Latest Market Research Report @ http://www.researchmoz.us/latest-report.html

Reasons to Buy

Understand the current systemic psoriasis marketed products landscape and recognize the dominant therapeutic agents and pharmaceutical players involved
Identify trends and developments within the psoriasis pipeline and consider how the future competitive environment will be impacted
Consider market opportunities and potential risks by examining the psoriasis clinical trial landscape in relation to industry averages
Observe projections for treatment usage patterns, annual therapy costs and market growth in the eight major markets and understand reasons for variance in projected patterns of growth in the eight major markets

1 Table of Contents 1
1.1 List of Tables 4
1.2 List of Figures 5

2 Executive Summary 6
2.1 Changes to Treatment Usage Patterns will Drive Market Growth 6
2.2 Biologics to Gain Prominence as Promising Novel Drugs Enter the Market 6

Browse All Countrywise Report @ http://www.researchmoz.us/country.html

Related Report

Global Radiation Therapy Market Report: 2013 Edition
(http://www.researchmoz.us/global-radiation-therapy-market-report-2013-edition-report.html)

Radiotherapy is used to kill cancerous cells and is commonly used either alone or in combination with surgery or chemotherapy. From conventional radiotherapy to advanced forms of treatment such as Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT) and proton therapy have become more widely accepted methods of treatment.

Dental Practices (Nordic) - Industry Report
(http://www.researchmoz.us/dental-practices-nordic-industry-report-report.html)

Plimsoll Publishing’s Dental Practices (Nordic) Analysis provides a detailed overview of the Dental Practices (Nordic) market and delivers a comprehensive individual analysis on the top 300 companies, including FOLKTANDVÅRDEN STOCKHOLMS LÄN AB, DISTRIKTSTANDVÅRDEN SVERIGE AB and SPECIALISTTANDLÄKARNA VALHALLAVÄGEN.This report (compiled in English language) includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Dental Practices (Nordic) analysis is ideal for anyone wanting.

About Us
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis.We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports.We provide our services to all sizes of organizations and across all industry verticals and markets.Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
http://www.researchmoz.us/
Blog: http://industryresearchnews.blogspot.com